- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00737880
Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation
A Prospective Randomized Multicenter Trial Comparing Histidine-Tryptophane-Ketoglutarate (HTK) Versus University of Wisconsin (UW) Perfusion Solution in Clinical Pancreas Transplantation
Graft preservation in clinical pancreas transplantation is based on hypothermia achieved by topic cooling and cold in situ flushing using special perfusion solutions designed to attenuate the effects of ischemia/reperfusion and prolong cold ischemia tolerance.
For pancreas transplantation, University of Wisconsin (UW) solution is the most commonly used perfusate. However, over the last years, Histidine-Tryptophan-Ketoglutarate (HTK) solution has been increasingly used for abdominal organ procurement. Retrospective reports published so far have demonstrated the safety of both perfusion solutions.
However, to date, no prospective study comparing both perfusion solutions has been published. Aim of this study was to prospectively evaluate early pancreas graft function in clinical pancreas transplantation after organ perfusion with HTK vs. UW solution.
The study hypothesis is that HTK is not inferior to UW for organ perfusion during procurement in clinical pancreas transplantation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Tyrol
-
Innsbruck, Tyrol, Austria, 6020
- Center of Operative Medicine / Department of Visceral, Transplant and Thoracic Surgery / Medical University Innsbruck
-
-
-
-
-
Gent, Belgium, 9000
- Department of General, Hepato-Biliary and Transplantation Surgery
-
-
-
-
-
Berlin, Germany, 13353
- Department of General, Visceral and Transplantation Surgery, Charite Campus Virchow Klinikum, Humboldt University Berlin
-
Rostock, Germany, 18057
- Department of General, Vascular, Thoracic and Transplantation Surgery, University of Rostock
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- brain dead, heart beating organ donor
- donor age 10 - 50 years
- donor body mass index < 30kg/m2
- pancreas cold ischemia time < 20 hours
- written informed consent of the pancreas recipient
Exclusion Criteria:
- missing written consent
- pancreas retransplantation
- recipient participation in another study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1
In situ organ perfusion using HTK solution during pancreas procurement
|
Usage of UW or HTK perfusion solution during in situ abdominal organ perfusion in multi-organ procurement
|
Active Comparator: 2
In situ perfusion using UW solution during pancreas procurement
|
Usage of UW or HTK perfusion solution during in situ abdominal organ perfusion in multi-organ procurement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pancreas graft survival
Time Frame: 6 months after transplantation
|
6 months after transplantation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Serum amylase
Time Frame: 6 months after transplantation
|
6 months after transplantation
|
Serum lipase
Time Frame: 6 months after transplantation
|
6 months after transplantation
|
C-peptide
Time Frame: 6 months after transplantation
|
6 months after transplantation
|
HbA1c
Time Frame: 6 months after transplantation
|
6 months after transplantation
|
Exogenous insulin requirement
Time Frame: 6 months after transplantation
|
6 months after transplantation
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Alfred Königsrainer, Prof., M.D., Transplantat Surgery, Medical University Innsbruck
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CL-KSM-III/6/00
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Organ perfusion during pancreas procurement
-
Medical University InnsbruckCompletedOrgan Preservation Solutions
-
Dr. F. Köhler Chemie GmbHCompletedHeart FailureAustria, Germany
-
Brigham and Women's HospitalMassachusetts General HospitalTerminatedLiver Diseases | Kidney Diseases | Bleeding Disorder | Spleen LesionUnited States
-
University of OxfordRecruiting
-
Accunea Ltd.Imperial College Healthcare NHS TrustRecruitingTransplant;Failure,KidneyUnited Kingdom
-
University Hospital OstravaRecruiting
-
Polyak, MaximilianHealth Resources and Services Administration (HRSA)CompletedLiver Transplantation | Organ Preservation
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
University Hospital, CaenTerumo Medical CorporationCompletedST-elevation Myocardial InfarctionFrance
-
Institute for Clinical and Experimental MedicineNot yet recruitingHeart Failure | Pulmonary Hypertension | Pulmonary Vascular Resistance AbnormalityCzechia